CorMedix Inc.
DE ˙ DB ˙ US21900C3088
6,91 € ↓ -0,13 (-1,79%)
2026-06-03
AKTIENPREIS
SecurityDE:19KA / CorMedix Inc.
InstitutionFmr Llc
Latest Disclosed Ownership5,739 shares
Latest Disclosed Value $ 38,965
Fmr Llc reports 95.36% decrease in ownership of 19KA / CorMedix Inc.

On May 15, 2026 - Fmr Llc filed a 13F-HR form disclosing ownership of 5,739 shares of CorMedix Inc. (DE:19KA) valued at $32,138 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 123,777 shares of CorMedix Inc.. This represents a change in shares of -95.36% during the quarter. The current value of the position is $39,634 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORMEDIX COM 21900C308 5,739 -118,038 -95.36 39 -97.36 0.0000
2026-02-17 2025-12-31 13F CORMEDIX COM 21900C308 123,777 115,393 1,376.35 1,440 1,383.51 0.0001
2025-11-13 2025-09-30 13F CORMEDIX COM 21900C308 8,384 608 7.82 98 2.11 0.0000
2025-08-14 2025-06-30 13F CORMEDIX COM 21900C308 7,776 958 14.05 96 131.71 0.0000
2025-05-12 2025-03-31 13F CORMEDIX COM 21900C308 6,818 -15,135 -68.94 42 -76.84 0.0000
2025-02-13 2024-12-31 13F CORMEDIX COM 21900C308 21,953 17,335 375.38 178 378.38 0.0000
2024-11-13 2024-09-30 13F CORMEDIX COM 21900C308 4,618 1,625 54.29 37 208.33 0.0000
2024-08-13 2024-06-30 13F CORMEDIX COM 21900C308 2,993 383 14.67 13 9.09 0.0000
2024-05-13 2024-03-31 13F CORMEDIX COM 21900C308 2,610 -564 -17.77 11 0.00 0.0000
2024-02-13 2023-12-31 13F CORMEDIX COM 21900C308 3,174 2,663 521.14 12 1,000.00 0.0000
2023-11-13 2023-09-30 13F CORMEDIX COM 21900C308 511 428 515.66 2 0.0000
2023-08-11 2023-06-30 13F CORMEDIX COM 21900C308 83 74 822.22 0 0.0000
2023-08-11 2023-03-31 13F/A-1 CORMEDIX COM 21900C308 9 0 0.00 0 0.0000
2023-05-11 2023-03-31 13F CORMEDIX COM 21900C308 9 0 0 0.0000
2023-02-13 2022-12-31 13F CORMEDIX COM 21900C308 9 -183 -95.31 0 -100.00 0.0000
2022-11-10 2022-09-30 13F CORMEDIX COM 21900C308 192 -11 -5.42 1 0.00 0.0000
2022-08-12 2022-06-30 13F CORMEDIX COM 21900C308 203 -1,765 -89.68 1 -90.91 0.0000
2022-05-13 2022-03-31 13F CORMEDIX COM 21900C308 1,968 1,968 11 0.0000
2020-11-13 2020-09-30 13F CORMEDIX COM 21900C308 0 -1,729 -100.00 0 -100.00
2020-08-24 2020-06-30 13F/A-1 CORMEDIX COM 21900C308 1,729 1,729 11 0.0000
2020-08-13 2020-06-30 13F CORMEDIX COM 21900C308 1,729 11
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.